Detalles de la búsqueda
1.
Toward personalized sexual medicine (part 1): integrating the "dual control model" into differential drug treatments for hypoactive sexual desire disorder and female sexual arousal disorder.
J Sex Med
; 10(3): 791-809, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23130782
2.
Toward personalized sexual medicine (part 3): testosterone combined with a Serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms.
J Sex Med
; 10(3): 824-37, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23130675
3.
Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues.
J Sex Med
; 10(3): 810-23, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23130748
4.
Childhood sexual abuse, selective attention for sexual cues and the effects of testosterone with or without vardenafil on physiological sexual arousal in women with sexual dysfunction: a pilot study.
J Sex Med
; 6(2): 429-39, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19138366
5.
Response to "toward personalized sexual medicine: where is the evidence?".
J Sex Med
; 11(9): 2359-63, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25052951
6.
The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunction.
J Sex Med
; 6(3): 777-90, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19207276
7.
The clitoral photoplethysmograph: a new way of assessing genital arousal in women.
J Sex Med
; 6(6): 1678-1687, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19473468
Resultados
1 -
7
de 7
1
Próxima >
>>